Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Clinical trial NCT03199586 · COMPLETED
Trial details
- NCT number
- NCT03199586
- Sponsor
- Novita Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2020-05-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.